David Hanley
Net worth: 114 720 $ as of 2026-05-30
Net worth: 114 720 $ as of 2026-05-30
David C.
Hanley is Chief Technical Operations Officer at Nuvation Bio, Inc. since 2021.
Formerly, Senior Director-Global Pharmaceutical Development at The Medicines Co. from 2011 to 2014, VP-Pharmaceutical Sciences & Technical Operations at Radius Health, Inc. from 2014 to 2018, and Senior VP & Head-Global Pharmaceutical Development at BioXcel Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Utah and an undergraduate degree from Virginia Commonwealth University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-26 | 24,000 ( 0.01% ) | 114 720 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| NUVATION BIO INC. | Chief Tech/Sci/R&D Officer | 2021-05-31 |
| Companies | Position | End |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-04-30 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 2018-07-31 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 2014-07-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Commonwealth University
Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Nuvation Bio, Inc.
Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Select your edition
All financial news and data tailored to specific country editions